Company: APM
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001213900-25-037669
Chunk: 177

Company: Aptorum Group Ltd
Filing Date: 2025-04-30
Form: 20-F
Item: Item 6
Chunk 177
---
 options, restricted shares or other awards to our directors,
employees and consultants. Awards will be made pursuant to agreements and may be subject to vesting and other restrictions as determined
by the board of directors.

21,853 options were granted
on March 15, 2019 to directors, employees, external consultants and advisors of the Group. One-half of each option grant vests on January
1, 2020 and expires on December 31, 2030, and the other half vests on January 1, 2021 and expires on December 31, 2031. The exercise price
is $129.1 per share, which was based on the closing price of the shares traded on the NASDAQ stock exchange on the trading day preceding
the grant date.

53,694 options were granted on March 16, 2020 to directors, employees,
external consultants and advisors of the Group. One-half of each option grant vests on January 1, 2021 and expires on December 31, 2031
and the other half vests on January 1, 2022, and expires on December 31, 2032. The exercise price is $29.9 per share, which was based
on the average closing price of the shares traded on the NASDAQ stock exchange for the five trading days immediately preceding the grant
date.

14,896 options were granted
on June 1, 2020 to directors and employees of the Group. Nearly one-half of each option grant vests on December 1, 2020 and expires on
November 30, 2030 and the remaining vests on January 1, 2021 and expires on December 31, 2031. The exercise price is US$31.1 per share,
which was based on the average closing price of the shares traded on the NASDAQ stock exchange for the five trading days immediately preceding
the grant date.

2,748 options were granted
on August 10, 2020 to Dr. Weiss, which will be vested on August 10, 2021 and expires on August 9, 2032. The exercise price is $36.4 per
share, which was based on the average closing price of the shares traded on the NASDAQ stock exchange for the five trading days immediately
preceding the grant date.

75,235 options were granted on March 11, 2021 to directors, employees,
external consultants and advisors of the Group with an exercise price of $27